|
|
|
|
|
(State or other jurisdiction of incorporation or organization
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
(Address of principal executive offices, including zip code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
None
|
N/A
|
N/A
|
|
Large accelerated filer ☐
|
Accelerated filer
|
☐
|
||
|
|
Smaller reporting company
|
|
Emerging growth company
|
|
Page
|
|||
|
PART I. FINANCIAL INFORMATION
|
|||
|
Item 1.
|
Financial Statements
|
||
| Condensed Balance Sheets – September 30, 2022 (Unaudited) and December 31, 2021 |
2
|
||
|
3
|
|||
| Condensed Statements of Operations for the Nine Months Ended September 30, 2022 and 2021 (Unaudited) | 4 |
||
|
5
|
|||
| Condensed Statements of Stockholders’ Equity for the Nine Months Ended September 30, 2022 and 2021 (Unaudited) | 6 |
||
|
7
|
|||
|
8
|
|||
|
Item 2.
|
10
|
||
|
Item 4.
|
14
|
||
|
PART II. OTHER INFORMATION
|
|||
|
Item 6.
|
15
|
||
|
16
|
|||
|
September 30,
2022
|
December 31,
2021
|
|||||||
|
(Unaudited)
|
(Note 1)
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Accounts receivable, net of allowance of $
|
|
|
||||||
|
Other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Property and equipment, net
|
|
|
||||||
|
Operating lease right-to-use asset
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Unexpired subscription revenue
|
$
|
|
$
|
|
||||
|
Accounts payable
|
|
|
||||||
|
Current portion of operating lease liability
|
|
|
||||||
|
Accrued expenses
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Deferred taxes on income, net
|
|
|
||||||
|
Unexpired subscription revenue, less current portion
|
|
|
||||||
|
Operating lease liability, less current portion
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Common stock, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total stockholders’ equity
|
|
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
||||
|
2022
|
2021
|
|||||||
|
Operating revenues
|
$
|
|
$
|
|
||||
|
Operating expenses:
|
||||||||
|
Data and product costs
|
|
|
||||||
|
Selling, general and administrative expenses
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Total operating expenses
|
|
|
||||||
|
Income from operations
|
|
|
||||||
|
Other income
|
|
|
||||||
|
Income before income taxes
|
|
|
||||||
|
Provision for income taxes
|
(
|
)
|
(
|
)
|
||||
|
Net income
|
$
|
|
$
|
|
||||
|
Net income per share – Basic and diluted
|
$
|
|
$
|
|
||||
|
Weighted average number of common shares outstanding –
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
|
2022
|
2021
|
|||||||
|
Operating revenues
|
$
|
|
$
|
|
||||
|
Operating expenses:
|
||||||||
|
Data and product costs
|
|
|
||||||
|
Selling, general and administrative expenses
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Total operating expenses
|
|
|
||||||
|
Income from operations
|
|
|
||||||
|
Other income
|
|
|
||||||
|
Income before income taxes
|
|
|
||||||
|
Provision for income taxes
|
(
|
)
|
(
|
)
|
||||
|
Net income
|
$
|
|
$
|
|
||||
|
Net income per share – Basic and diluted
|
$ |
$
|
|
|||||
|
Weighted average number of common shares outstanding –
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
| Additional |
Total
|
|||||||||||||||||||
| Common Stock |
Paid-in
Capital
|
Accumulated
Deficit
|
Stockholders’ Equity
|
|||||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||||||
|
Balance July 1, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Balance July 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
| Additional | Total | |||||||||||||||||||
|
Common Stock
|
Paid-in
Capital
|
Accumulated
Deficit
|
Stockholders’
Equity
|
|||||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||||||
|
Balance January 1, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Balance January 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Net income
|
-
|
|
|
|
|
|||||||||||||||
|
Stock-based compensation
|
-
|
|
|
|
|
|||||||||||||||
|
Balance September 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
2022
|
2021
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Deferred income taxes
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Operating lease right-to-use asset, net
|
|
|
||||||
|
Stock-based compensation
|
|
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(
|
)
|
|
|||||
|
Other current assets
|
(
|
)
|
|
|||||
|
Other assets
|
|
|
||||||
|
Unexpired subscription revenue
|
|
(
|
)
|
|||||
|
Accounts payable
|
(
|
)
|
(
|
)
|
||||
|
Accrued expenses
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Sale of available-for-sale securities – municipal bonds
|
|
|
||||||
|
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Net cash (used in) provided by investing activities
|
(
|
)
|
|
|||||
|
Net increase in cash and cash equivalents
|
|
|
||||||
|
Cash and cash equivalents at beginning of period
|
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
|
3 Months Ended
September 30,
|
9 Months Ended
September 30,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
|||||||||||||
|
Data and product costs
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
|
Selling, general and administrative expenses
|
|
|
|
|
||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
|
September 30, 2022
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
December 31, 2021
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
3 Months Ended
September 30,
|
9 Months Ended
September 30,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
|||||||||||||
|
Weighted average number of common shares outstanding – basic
|
|
|
|
|
||||||||||||
|
Potential shares exercisable under stock option plans
|
|
|
|
|
||||||||||||
| LESS: Shares which could be repurchased under treasury stock method | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
Weighted average number of common shares outstanding – diluted
|
|
|
|
|
||||||||||||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
September 30,
2022
|
December 31,
2021
|
|||||||
|
Cash and cash equivalents
|
$
|
13,606
|
$
|
12,382
|
||||
|
Accounts receivable, net
|
$
|
2,951
|
$
|
2,803
|
||||
|
Working capital
|
$
|
5,230
|
$
|
3,964
|
||||
|
Cash ratio
|
1.13
|
1.05
|
||||||
|
Quick ratio
|
1.37
|
1.29
|
||||||
|
Current ratio
|
1.43
|
1.34
|
||||||
|
3 Months Ended September 30,
|
||||||||||||||||
|
2022
|
2021
|
|||||||||||||||
|
Amount
|
% of Total
Operating
Revenues
|
Amount
|
% of Total
Operating
Revenues
|
|||||||||||||
|
Operating revenues
|
$
|
4,547,708
|
100
|
%
|
$
|
4,323,676
|
100
|
%
|
||||||||
|
Operating expenses:
|
||||||||||||||||
|
Data and product costs
|
1,644,489
|
36
|
%
|
1,519,860
|
35
|
%
|
||||||||||
|
Selling, general and administrative expenses
|
2,230,553
|
49
|
%
|
2,024,562
|
47
|
%
|
||||||||||
|
Depreciation and amortization
|
100,448
|
2
|
%
|
75,067
|
2
|
%
|
||||||||||
|
Total operating expenses
|
3,975,490
|
87
|
%
|
3,619,489
|
84
|
%
|
||||||||||
|
Income from operations
|
572,218
|
13
|
%
|
704,187
|
16
|
%
|
||||||||||
|
Other income, net
|
54,581
|
1
|
%
|
263
|
0
|
%
|
||||||||||
|
Income before income taxes
|
626,799
|
14
|
%
|
704,450
|
16
|
%
|
||||||||||
|
Provision for income taxes
|
(140,822
|
)
|
(3
|
%)
|
(209,098
|
)
|
(5
|
%)
|
||||||||
|
Net income
|
$
|
485,977
|
11
|
%
|
$
|
495,352
|
11
|
%
|
||||||||
|
9 Months Ended September 30,
|
||||||||||||||||
|
2022
|
2021
|
|||||||||||||||
|
Amount
|
% of Total
Operating
Revenues
|
Amount
|
% of Total
Operating
Revenues
|
|||||||||||||
|
Operating revenues
|
$
|
13,335,927
|
100
|
%
|
$
|
12,704,756
|
100
|
%
|
||||||||
|
Operating expenses:
|
||||||||||||||||
|
Data and product costs
|
5,117,975
|
38
|
%
|
4,721,331
|
37
|
%
|
||||||||||
|
Selling, general and administrative expenses
|
6,864,354
|
52
|
%
|
6,415,736
|
50
|
%
|
||||||||||
|
Depreciation and amortization
|
301,656
|
2
|
%
|
206,083
|
2
|
%
|
||||||||||
|
Total operating expenses
|
12,283,985
|
92
|
%
|
11,343,150
|
89
|
%
|
||||||||||
|
Income from operations
|
1,051,942
|
8
|
%
|
1,361,606
|
11
|
%
|
||||||||||
|
Other income, net
|
66,368
|
0
|
%
|
3,756
|
0
|
%
|
||||||||||
|
Income before income taxes
|
1,118,310
|
8
|
%
|
1,365,362
|
11
|
%
|
||||||||||
|
Provision for income taxes
|
(268,544
|
)
|
(2
|
%)
|
(359,588
|
)
|
(3
|
%)
|
||||||||
|
Net income
|
$
|
849,766
|
6
|
%
|
$
|
1,005,774
|
8
|
%
|
||||||||
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
CREDITRISKMONITOR.COM, INC.
|
|||
|
(REGISTRANT)
|
|||
|
Date: November 10, 2022
|
By:
|
/s/ Steven Gargano
|
|
| Steven Gargano | |||
| Senior Vice President & Chief Financial Officer | |||
| (Principal Accounting Officer) | |||